Clinical Trial Update: Research on Human Insulin rDNA Safety and Efficacy in Patients With Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 trial updating safety and efficacy data for human insulin recombinant DNA in patients with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Human insulin rDNA (human insulin recombinant DNA)

Snippet

Sponsor: Getz Pharma | Conditions: Adverse Drug Event, Effect of Drug | Phase 4 | Status: COMPLETED